Leading Pipracan 4.5 Injection, Supplier from INDIA to Washington, USA | City Drug Exporters
City Drug Exporters supplies (Pipracan 4.5 Injection), from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies
Pipracan 4.5 Injection is a combination antibiotic composed of 4000 mg of piperacillin (an extended-spectrum penicillin) and 500 mg of tazobactam (a beta-lactamase inhibitor). It treats severe, systemic bacterial infections by inhibiting bacterial cell wall synthesis and neutralizing resistance enzymes, allowing the medication to overpower a broad range of pathogens.
Mechanism of Action
Piperacillin Action: Binds to bacterial penicillin-binding proteins (PBPs), halting cell wall synthesis and causing cell death.
Tazobactam Action: Inhibits beta-lactamase enzymes produced by bacteria, protecting piperacillin from being broken down and destroyed.
Synergy: Tazobactam expands the spectrum of activity against resistant strains that would normally inactivate piperacillin alone.
Pharmacokinetics
Distribution: Distributes widely into lung tissue, bile, intestinal mucosa, and interstitial fluid. It does not easily penetrate the blood-brain barrier.
Metabolism: Piperacillin is minimally metabolized; tazobactam is metabolized into a single, inactive metabolite.
Excretion: Both drugs are excreted primarily by the kidneys through glomerular filtration and tubular secretion. Dose adjustments are required for patients with renal impairment.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug Exporters supplies (Pipracan 4.5 Injection), from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies
Pipracan 4.5 Injection is a combination antibiotic composed of 4000 mg of piperacillin (an extended-spectrum penicillin) and 500 mg of tazobactam (a beta-lactamase inhibitor). It treats severe, systemic bacterial infections by inhibiting bacterial cell wall synthesis and neutralizing resistance enzymes, allowing the medication to overpower a broad range of pathogens.
Mechanism of Action
Piperacillin Action: Binds to bacterial penicillin-binding proteins (PBPs), halting cell wall synthesis and causing cell death.
Tazobactam Action: Inhibits beta-lactamase enzymes produced by bacteria, protecting piperacillin from being broken down and destroyed.
Synergy: Tazobactam expands the spectrum of activity against resistant strains that would normally inactivate piperacillin alone.
Pharmacokinetics
Distribution: Distributes widely into lung tissue, bile, intestinal mucosa, and interstitial fluid. It does not easily penetrate the blood-brain barrier.
Metabolism: Piperacillin is minimally metabolized; tazobactam is metabolized into a single, inactive metabolite.
Excretion: Both drugs are excreted primarily by the kidneys through glomerular filtration and tubular secretion. Dose adjustments are required for patients with renal impairment.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
